Literature DB >> 24211724

LC-MS/MS characterization of forced degradation products of zofenopril.

Thippani Ramesh1, Pothuraju Nageswara Rao, Ramisetti Nageswara Rao.   

Abstract

A rapid, specific and reliable isocratic LC-MS/MS method has been developed and validated for the identification and characterization of stressed degradation products of Zofenopril. Zofenopril, an anti-hypertensive drug, was subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolysis and thermal stress, as per ICH-specified conditions. The drug showed extensive degradation under oxidative and base hydrolysis stress conditions. However, it was stable to thermal, acid, neutral and photolysis stress conditions. A total of 6 degradation products were observed and the chromatographic separation of the drug and its degradation products were achieved on Phenomenex (Luna) C18 (250mm×4.6mm, i.d., 5μm) column using 20mM ammonium acetate: acetonitrile (50:50, v/v) as a mobile phase. The degradation products were characterized by LC-MS/MS and its fragmentation pathways were proposed. The LC-MS method was validated with respect to specificity, linearity, accuracy and precision. No previous reports were found in the literature regarding the degradation behavior of zofenopril.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Characterization; Forced degradation; LC–MS/MS; Validation; Zofenopril

Mesh:

Substances:

Year:  2013        PMID: 24211724     DOI: 10.1016/j.jpba.2013.10.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Structural confirmation of sulconazole sulfoxide as the primary degradation product of sulconazole nitrate.

Authors:  Qun Xu; Ashraf Khan; Di Gao; Kristie M Adams; Fatkhulla Tadjimukhamedov; Shane Tan; John T Simpson
Journal:  J Pharm Anal       Date:  2017-12-19

Review 2.  Choices of chromatographic methods as stability indicating assays for pharmaceutical products: A review.

Authors:  Yik-Ling Chew; Mei-Ann Khor; Yau-Yan Lim
Journal:  Heliyon       Date:  2021-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.